EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)

Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations

(2015) Longding Liu et al.   BMC Medicine

Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide

(2015) Lianlian Bian et al.   Expert Review of Anti-Infective Therapy

Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012-2013

(2015) Xin Yao et al.   JOURNAL OF MEDICAL VIROLOGY

An Outbreak of Kingella kingae Infections Associated with Hand, Foot and Mouth Disease/Herpangina Virus Outbreak in Marseille, France, 2013

(2015) Nawal El Houmami et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse

(2015) Chia-Ying Wu et al.   PLoS One

Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014

(2015) She-Lan Liu et al.   REVIEWS IN MEDICAL VIROLOGY

High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice

(2015) Chao Zhang et al.   VACCINE

Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice

(2015) Hui Zhao et al.   Scientific Reports

Is a multivalent hand, foot, and mouth disease vaccine feasible?

(2015) Michel Klein et al.   Human Vaccines & Immunotherapeutics

Review of Enterovirus 71 Vaccines

(2014) P. Chong et al.   CLINICAL INFECTIOUS DISEASES

Hand, foot and mouth disease in Guangdong, China, in 2013: new trends in the continuing epidemic

(2014) J. Lu et al.   CLINICAL MICROBIOLOGY AND INFECTION

Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: Coxsackievirus A6 has emerged as the predominant causative agent

(2014) Jin-Lin Li et al.   JOURNAL OF INFECTION

Characterization of the enterovirus 71 VP1 protein as a vaccine candidate

(2014) Shi-Li Zhou et al.   JOURNAL OF MEDICAL VIROLOGY

Hand, foot, and mouth disease in China, 2008–12: an epidemiological study

(2014) Weijia Xing et al.   LANCET INFECTIOUS DISEASES

An Inactivated Enterovirus 71 Vaccine in Healthy Children

(2014) Rongcheng Li et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China

(2014) Fengcai Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence and Characterization of Enterovirus Infections among Pediatric Patients with Hand Foot Mouth Disease, Herpangina and Influenza Like Illness in Thailand, 2012

(2014) Jiratchaya Puenpa et al.   PLoS One

Analysis of Cross-Reactive Neutralizing Antibodies in Human HFMD Serum with an EV71 Pseudovirus-Based Assay

(2014) Huafei Zhang et al.   PLoS One

Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases

(2014) Chia-Chyi Liu et al.   VACCINE

A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice

(2014) Zhiqiang Ku et al.   VACCINE

Update on enterovirus 71 infection

(2014) Peng-Nien Huang et al.   Current Opinion in Virology

Characterization of the enterovirus 71 P1 polyprotein expressed inPichia pastoras a candidate vaccine

(2014) Xue Han et al.   Human Vaccines & Immunotherapeutics

Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial

(2014) Yi-Juan Chen et al.   Human Vaccines & Immunotherapeutics

Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice

(2014) Shiyang Sun et al.   Human Vaccines & Immunotherapeutics

Immunogenicity Studies of Bivalent Inactivated Virions of EV71/CVA16 Formulated with Submicron Emulsion Systems

(2014) Chih-Wei Lin et al.   Biomed Research International

Immunogenicity, Safety, and Lot Consistency of a Novel Inactivated Enterovirus 71 Vaccine in Chinese Children Aged 6 to 59 Months

(2013) Yue-Mei Hu et al.   Clinical and Vaccine Immunology

An outbreak of hand, foot and mouth disease in bhubaneswar, Odisha

(2013) Bikash Ranjan Kar et al.   INDIAN PEDIATRICS

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2013) Feng-Cai Zhu et al.   LANCET

The Cross-Neutralizing Activity of Enterovirus 71 Subgenotype C4 Vaccines in Healthy Chinese Infants and Children

(2013) Qunying Mao et al.   PLoS One

Formalin-Inactivated EV71 Vaccine Candidate Induced Cross-Neutralizing Antibody against Subgenotypes B1, B4, B5 and C4A in Adult Volunteers

(2013) Ai-Hsiang Chou et al.   PLoS One

A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine

(2013) Aristine Cheng et al.   VACCINE

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine

(2013) Shi-Hsia Hwa et al.   PLoS Neglected Tropical Diseases

Immunological Evaluation and Comparison of Different EV71 Vaccine Candidates

(2012) Ai-Hsiang Chou et al.   Clinical & Developmental Immunology

Emerging human papillomavirus vaccines

(2012) Barbara Ma et al.   EXPERT OPINION ON EMERGING DRUGS

Comparative Analysis of the Immunogenicity and Protective Effects of Inactivated EV71 Vaccines in Mice

(2012) Qunying Mao et al.   PLoS One

Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles

(2012) Yu-Li Lin et al.   VACCINE

A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

(2012) John T. Schiller et al.   VACCINE

Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trial

(2012) Yan-Ping Li et al.   VACCINE

Production of EV71 vaccine candidates

(2012) Pele Chong et al.   Human Vaccines & Immunotherapeutics

Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children

(2012) Fan-Yue Meng et al.   Human Vaccines & Immunotherapeutics

Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71

(2011) Qunying Mao et al.   ARCHIVES OF VIROLOGY

Purification and Characterization of Enterovirus 71 Viral Particles Produced from Vero Cells Grown in a Serum-Free Microcarrier Bioreactor System

(2011) Chia-Chyi Liu et al.   PLoS One

The Persistent Circulation of Enterovirus 71 in People's Republic of China: Causing Emerging Nationwide Epidemics Since 2008

(2011) Xiaojuan Tan et al.   PLoS One

Next generation dengue vaccines: A review of candidates in preclinical development

(2011) Julia Schmitz et al.   VACCINE

Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines

(2011) Zhenglun Liang et al.   VACCINE

Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine

(2011) Chun-Wei Chen et al.   VACCINE

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

(2011) Jui-Yuan Chang et al.   VACCINE

Comparison of Clinical Features Between Coxsackievirus A2 and Enterovirus 71 During the Enterovirus Outbreak in Taiwan, 2008: A Children's Hospital Experience

(2010) Shih-Perng Chen et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Enterovirus 71 in Taiwan

(2008) Luan-Yin Chang   Pediatrics and Neonatology

Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development

(2008) Stephen J. Thomas et al.   VACCINE